TARGET AUDIENCE
This educational activity is intended for endocrinologists and health care professionals who care for patients with hypoparathyroidism.

PROGRAM OVERVIEW
This initiative is designed to improve knowledge and skills of adult endocrinologists and other members of the endocrine care team to support their abilities to critically evaluate patients with hypoparathyroidism and how to appropriately incorporate genetic testing into the diagnostic process for ADH1.

Upon completion of this activity, the learners should be able to:

• Recognize the importance of identifying autosomal dominant hypocalcemia type 1 (ADH1) as a cause of hypoparathyroidism
• Apply appropriate diagnostic strategies for suspected ADH1, including key considerations related to genetic testing
• Explain to the patient the role of genetic testing in the diagnostic process for ADH1

FACULTY
Dolores Shoback, MD
Endocrinologist
University of California, San Francisco
San Francisco, CA

Michael Collins, MD
Senior Clinical Advisor
National Institutes of Health
Bethesda, MD

PLANNING COMMITTEE
Dolores Shoback, MD
Endocrinologist
University of California, San Francisco
San Francisco, CA

Michael Collins, MD
Senior Clinical Advisor
National Institutes of Health
Bethesda, MD

Margaret Das, PhD
Medical Writer
The France Foundation
Old Lyme, CT

CONTENT REVIEWERS
Crystal Loucel, MPH, MS, RN, CDCES
Clinical Research Nurse
University of California, San Francisco
Department of Surgery
Division of Transplant Research
San Francisco, CA

Nicholas Klock, PA-C
Internal Medicine
Middlesex Health
Middletown, CT

ACCREDITATION STATEMENT

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

PHYSICIAN CREDIT DESIGNATION
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
The France Foundation designates this activity for 1.0 contact hour.

PHYSICIAN ASSISTANTS
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until June 29, 2027. PAs should only claim credit commensurate with the extent of their participation.

All other health care professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all individuals in a position to control the content of this educational activity must disclose all relevant financial relationships with ineligible companies. All identified conflicts of interest are reviewed and mitigated to ensure independence, objectivity, balance, and scientific rigor.

This activity adheres to generally accepted standards of scientific integrity, including requirements for appropriate study design, data collection, and analysis. The organizers of this activity are committed to providing high-quality CME/CE that promotes improvements in health care and serves the needs of learners and not commercial interests. When applicable, collaborating partners participate in the disclosure and mitigation process.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

Faculty for this educational activity are required to disclose when a therapy or procedure being discussed is off-label, unlabeled, experimental or investigational, and to note any limitations of the data presented (e.g., preliminary findings, ongoing research, or expert opinion).

Some faculty may discuss uses of pharmaceutical agents or devices that are not included in U.S. Food and Drug Administration–approved labeling. These discussions are provided solely for educational purposes and should not be construed as a recommendation for any particular use. Learners are encouraged to review full prescribing information for products discussed.

This activity is supported by an independent medical educational grant BridgeBio.

This activity is intended for health care professionals for educational purposes only. The content reflects information available at the time of development and may not represent the most current evidence, regulatory status, or prescribing information. Participants should consult current package inserts, clinical guidelines, and institutional policies before prescribing medications or making clinical decisions.

This activity has been planned and implemented in compliance with applicable accreditation standards to ensure that content is fair, balanced, evidence-based, and free of commercial bias.